Project Grant HT94252510902
Award Date
9/1/25
Completion Date
8/31/29
Dollars Obligated
$3.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
William Penn Annex West, PA 19107, USA
Similar Awards
This Project Grant award of $624,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to Thomas Jefferson University (Sidney Kimmel Medical College) supports research to identify mechanisms of tolerance and resistance to the combination of darovasertib and crizotinib in uveal melanoma. The research aims to transform healthcare for military service members, veterans, and the public through innovative biomedical investigations focused on disease...
This federal Project Grant award of $858,000.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports a longitudinal analysis of the mesenchymal cell state from melanoma initiation to metastatic progression at Thomas Jefferson University's Sidney Kimmel Medical College. The award, effective August 1, 2024, with a completion date of July 31, 2027, funds advanced biomedical research aimed at transforming healthcare for...
The U.S. Department of Defense's Defense Health Agency awarded a $780,000 Project Grant to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, for a 3-year research project titled "DEGRADATION OF MUTANT GNAQ 11 IN UVEAL MELANOMA CELLS". The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research related to military medicine, including cancer, neurological disorders, and other conditions...
The Defense Health Agency awarded a $756,897 Project Grant to Thomas Jefferson University, doing business as the Sidney Kimmel Medical College, for the federal grant program "Military Medical Research and Development" (CFDA 12.420). The grant, effective August 1, 2024 through July 31, 2027, will support "Second-Generation Precision Medicine for BRCA-Mutant Ovarian Cancer" research. Thomas Jefferson University, a leading academic medical center known for its innovative medical...
The Department of the Army Medical Command awarded Thomas Jefferson University a $841,473 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop occult colorectal cancer elimination through GUCY2C-directed immunotherapy. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
The Department of the Army Medical Command awarded a $592,646 Project Grant to Thomas Jefferson University's Sidney Kimmel Medical College on September 1, 2022 to fund research titled "Slow Proliferation of BAP1-Mutant Uveal Melanoma Cells and Its Role in Metastasis." The grant is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care...
The federal Project Grant award of $848,335.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program supports a research initiative titled "NOVEL THERAPEUTIC APPROACH TO PREVENT UVEAL MELANOMA PROGRESSION" at the University of Nebraska Medical Center (UNMC). This 3-year award, running from August 1, 2025 to July 31, 2028, will fund advanced biomedical research aimed at transforming healthcare for military service members,...
Thomas Jefferson University, doing business as Sidney Kimmel Medical College, was awarded a $234,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year grant will fund research into precision therapies for metastatic uveal melanoma prevention and treatment by investigating multimodal GNAQ signaling pathways. Through September 2021 to August 2024, Sidney Kimmel Medical College researchers will work to transform...
The Department of Defense's Defense Health Agency awarded a $558,832 Project Grant to Tufts University School of Medicine under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2024. This grant will support research focused on "Targeting Differentiation Epitope in CD11b of Tumor-Associated Inflammatory Monocytes: A Novel Adjuvant Dendritic Cell Therapy Approach for Mucosal Melanoma." The research aims to develop an innovative dendritic cell-based...
Thomas Jefferson University will receive $3,052,929 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to research occult colorectal cancer elimination by GUCY2C-directed immunotherapy from July 1, 2022 to June 30, 2026. Specifically, the Sidney Kimmel Medical College of Thomas Jefferson University will investigate medical solutions for the battlefield and transform healthcare for service members and the public through...